Author

Wubing Zhang

Primary ORCID profile (0000-0003-2233-299X · 4 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Wubing ZhangiD4 papers · Harvard University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Ailu Mading· 1 shared Binbin Wang· 1 shared Feizhen WuiD· 1 shared Hailing Liu· 1 shared Hang Liu· 1 shared Hao Chen· 1 shared Mei Wang· 1 shared Qilong Chen· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ailu Mading

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 21, 2018

CRISPR/Cas9 screens Reveal Dasatinib Targets of Inhibiting T cell Activation and Proliferation

Mei Wang, Qilong Chen, Hailing Liu…·Feizhen Wu

This study identifies dasatinib targets in T cell activation and proliferation using CRISPR/Cas9 screening in Jurkat cells, revealing both known and novel targets and their functional roles.

DOI 10.1101/448662

humangenetic perturbation / CRISPR

𝕏 PostBluesky